WNT signaling and cancer stemness
M Katoh, M Katoh - Essays in biochemistry, 2022 - portlandpress.com
Cancer stemness, defined as the self-renewal and tumor-initiation potential of cancer stem
cells (CSCs), is a cancer biology property featuring activation of CSC signaling networks …
cells (CSCs), is a cancer biology property featuring activation of CSC signaling networks …
[HTML][HTML] Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Lipids, the basic components of the cell membrane, execute fundamental roles in almost all
the cell activities including cell-cell recognition, signalling transduction and energy supplies …
the cell activities including cell-cell recognition, signalling transduction and energy supplies …
Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching
C Chen, S Zhao, X Zhao, L Cao, A Karnad… - Cell Death & …, 2022 - nature.com
Chemoresistance in pancreatic cancer cells may be caused by the expansion of inherently
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …
resistant cancer cells or by the adaptive plasticity of initially sensitive cancer cells. We …
[HTML][HTML] Regulation of cancer stem cells in triple negative breast cancer
N Fultang, M Chakraborty… - Cancer Drug …, 2021 - ncbi.nlm.nih.gov
Abstract Triple Negative Breast Cancer (TNBC) is the most lethal subtype of breast cancer.
Despite the successes of emerging targeted therapies, relapse, recurrence, and therapy …
Despite the successes of emerging targeted therapies, relapse, recurrence, and therapy …
Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism
Significance: Nuclear factor erythroid 2 (NFE2)-related factor 2 (NFE2L2, or NRF2) is a
transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays …
transcription factor predominantly affecting the expression of antioxidant genes. NRF2 plays …
Inflammation-driven breast tumor cell plasticity: Stemness/EMT, therapy resistance and dormancy
T Baram, L Rubinstein-Achiasaf, H Ben-Yaakov… - Frontiers in …, 2021 - frontiersin.org
Cellular heterogeneity poses an immense therapeutic challenge in cancer due to a constant
change in tumor cell characteristics, endowing cancer cells with the ability to dynamically …
change in tumor cell characteristics, endowing cancer cells with the ability to dynamically …
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Y Sun, Z Wang, L Na, D Dong, W Wang, C Zhao - Cell Death & Disease, 2020 - nature.com
Chemotherapy currently remains the standard treatment for triple-negative breast cancer
(TNBC). However, TNBC frequently develop chemoresistance, which is responsible for …
(TNBC). However, TNBC frequently develop chemoresistance, which is responsible for …
Potential role of MSC/cancer cell fusion and EMT for breast cancer stem cell formation
R Hass, J von der Ohe, H Ungefroren - Cancers, 2019 - mdpi.com
Solid tumors comprise of maturated cancer cells and self-renewing cancer stem-like cells
(CSCs), which are associated with various other nontumorigenic cell populations in the …
(CSCs), which are associated with various other nontumorigenic cell populations in the …
Clinically translatable approaches of inhibiting TGF-β to target cancer stem cells in TNBC
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that disproportionally
accounts for the majority of breast cancer-related deaths due to the lack of specific targets for …
accounts for the majority of breast cancer-related deaths due to the lack of specific targets for …
Cancer stem cells in ovarian cancer—a source of tumor success and a challenging target for novel therapies
JR Wilczyński, M Wilczyński, E Paradowska - International Journal of …, 2022 - mdpi.com
Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite
indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance …
indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance …